Table S5. Factors associated with hospital mortality in immunocompromised patients. Multivariate logistic regression model describing the factors associated with hospital mortality in immunocompromised patients. (PDF 49Â kb
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Table S2. Factors associated with the use of noninvasive ventilation. Multivariate logistic regressi...
Table S7. Patient characteristics and clinical endpoints of immunocompetent patients, according to t...
Table S8. Patientsâ characteristics and clinical endpoints of immunocompromised (study) patients, ...
List of LUNG SAFE investigators. Names and affiliations of the LUNG SAFE investigators. (PDF 172Â kb
Table S4. Adjunctive measures/therapies during at least one day during follow-up in immunocompetent ...
Figure S2. This figure shows a Kaplan-Meier curve for hospital survival of immunocompromised patient...
Table S3. Ventilator settings during the first day of ARDS in the immunocompetent (Control) and immu...
Figure S1. Kaplan-Meier curve for hospital survival in immunocompromised patients according to ARDS ...
Table S6. Ventilator settings during the first day of ARDS in immunocompetent (Control) and immunoco...
Contains fulltext : 196401.pdf (publisher's version ) (Open Access)BACKGROUND: The...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Table S2. Factors associated with the use of noninvasive ventilation. Multivariate logistic regressi...
Table S7. Patient characteristics and clinical endpoints of immunocompetent patients, according to t...
Table S8. Patientsâ characteristics and clinical endpoints of immunocompromised (study) patients, ...
List of LUNG SAFE investigators. Names and affiliations of the LUNG SAFE investigators. (PDF 172Â kb
Table S4. Adjunctive measures/therapies during at least one day during follow-up in immunocompetent ...
Figure S2. This figure shows a Kaplan-Meier curve for hospital survival of immunocompromised patient...
Table S3. Ventilator settings during the first day of ARDS in the immunocompetent (Control) and immu...
Figure S1. Kaplan-Meier curve for hospital survival in immunocompromised patients according to ARDS ...
Table S6. Ventilator settings during the first day of ARDS in immunocompetent (Control) and immunoco...
Contains fulltext : 196401.pdf (publisher's version ) (Open Access)BACKGROUND: The...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...
Background: The aim of this study was to describe data on epidemiology, ventilatory management, and ...